Mallinckrodt Pharmaceuticals Blog

Kratom.org - Kratom Strains & Vendors Reviewed

Skip to content
  • Home
  • Achievements
  • Advocacy
  • Culture
  • History
  • Philanthropy
  • Website

Pride

MNK CEO Mark Trudeau on the Value of an Inclusive Workplace

  • by Brendan Boylan
  • Posted on June 30, 2020September 30, 2020
  • Culture

I’ve had the pleasure of being a 35+ year veteran of the biopharmaceutical industry, and during that time, I have seen some incredible innovations which have led to dramatic improvements in human health. Earlier in […]

Read More

Mallinckrodt Supports LGBTQ Pride Celebration in New Jersey

  • by Brendan Boylan
  • Posted on June 23, 2019
  • Advocacy

Mallinckrodt showed its support for the lesbian, gay, bisexual, transgender and queer (LGBTQ) community, taking part in the 28th annual LGBTQ Pride Celebration in Asbury Park, NJ on June 2. More than 50 people participated, […]

Read More

Mallinckrodt Shows Support, Solidarity During Pride Month

  • by Gena Holthaus
  • Posted on July 17, 2017October 6, 2017
  • Advocacy

More than 150 Mallinckrodt employees joined with family and friends to show support for and solidarity with the lesbian, gay, bisexual and transgender (LGBT) community by participating in Pride festivities in New Jersey and St. […]

Read More
  • NICU Awareness Month: Experts Share Advice on What to Expect in the NICU

    September 30, 2020
  • Mallinckrodt Volunteers Assemble and Distribute PPE for the St. Louis Community

    August 19, 2020
  • MNK CEO Mark Trudeau on the Value of an Inclusive Workplace

    June 30, 2020
  • An Open Letter from Mallinckrodt CEO Mark Trudeau on Diversity and Inclusion

    June 3, 2020
  • Creating a sense of community during times of isolation: Patient advocacy groups respond to the COVID-19 crisis

    May 29, 2020

Featured Video

Categories

  • Achievements
  • Advocacy
  • Culture
  • History
  • Media
  • Philanthropy
  • Uncategorized

Latest Posts

NICU Awareness Month: Experts Share Advice on What to Expect in the NICU

Mallinckrodt Volunteers Assemble and Distribute PPE for the St. Louis Community

MNK CEO Mark Trudeau on the Value of an Inclusive Workplace

An Open Letter from Mallinckrodt CEO Mark Trudeau on Diversity and Inclusion

Creating a sense of community during times of isolation: Patient advocacy groups respond to the COVID-19 crisis

Subscribe via Email

Enter your email address to subscribe and receive notifications of new posts by email.

About Mallinckrodt Pharmaceuticals

Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; and analgesics and hemostasis products. The company's core strengths include the acquisition and management of highly regulated raw materials and specialized chemistry, formulation and manufacturing capabilities. The company's Specialty Brands segment includes branded medicines and its Specialty Generics segment includes specialty generic drugs, active pharmaceutical ingredients and external manufacturing.

Visit Our Corporate Website

About Us

Products

Core Strengths

Corporate Social Responsibility

Investor Relations

Careers

Connect & Share

RSS
LinkedIn

Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2015 Mallinckrodt.

Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at Damastown, Mulhuddart, Dublin 15, Ireland.